ZIOPHARM Oncology, Inc. (ZIOP.OB) Announces Second Quarter Financial Results and Updates Key Development Activities
8/9/2013 8:58:38 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BOSTON, Aug. 8, 2013 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced financial results for the second quarter ended June 30, 2013, and provided an update on the Company's key development activities, including advances in its synthetic biology platform with Channel Collaborator Intrexon Corporation.
Help employers find you! Check out all the jobs and post your resume.
comments powered by